0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Corticosteroid Injections for Joint Pain Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-13D9473
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Corticosteroid Injections for Joint Pain Market Insights and Forecast to 2028
BUY CHAPTERS

Global Corticosteroid Injections for Joint Pain Market Research Report 2025

Code: QYRE-Auto-13D9473
Report
July 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Corticosteroid Injections for Joint Pain Market Size

The global market for Corticosteroid Injections for Joint Pain was valued at US$ 2399 million in the year 2024 and is projected to reach a revised size of US$ 3610 million by 2031, growing at a CAGR of 6.1% during the forecast period.

Corticosteroid Injections for Joint Pain Market

Corticosteroid Injections for Joint Pain Market

Corticosteroid Injections products used for Joint Pain.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Corticosteroid Injections for Joint Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Corticosteroid Injections for Joint Pain.
The Corticosteroid Injections for Joint Pain market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Corticosteroid Injections for Joint Pain market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Corticosteroid Injections for Joint Pain manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Corticosteroid Injections for Joint Pain Market Report

Report Metric Details
Report Name Corticosteroid Injections for Joint Pain Market
Accounted market size in year US$ 2399 million
Forecasted market size in 2031 US$ 3610 million
CAGR 6.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Allergan, Pfizer, Sanofi, Anika Therapeutics, Ferring, Bioventus, Flexion Therapeutics, Zimmer Biomet, SEIKAGAKU, Chugai Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Corticosteroid Injections for Joint Pain manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Corticosteroid Injections for Joint Pain in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Corticosteroid Injections for Joint Pain Market growing?

Ans: The Corticosteroid Injections for Joint Pain Market witnessing a CAGR of 6.1% during the forecast period 2025-2031.

What is the Corticosteroid Injections for Joint Pain Market size in 2031?

Ans: The Corticosteroid Injections for Joint Pain Market size in 2031 will be US$ 3610 million.

Who are the main players in the Corticosteroid Injections for Joint Pain Market report?

Ans: The main players in the Corticosteroid Injections for Joint Pain Market are Allergan, Pfizer, Sanofi, Anika Therapeutics, Ferring, Bioventus, Flexion Therapeutics, Zimmer Biomet, SEIKAGAKU, Chugai Pharma

What are the Application segmentation covered in the Corticosteroid Injections for Joint Pain Market report?

Ans: The Applications covered in the Corticosteroid Injections for Joint Pain Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Corticosteroid Injections for Joint Pain Market report?

Ans: The Types covered in the Corticosteroid Injections for Joint Pain Market report are Knee & Ankle, Hip Joint, Shoulder & Elbow, Facet Joints of the Spine, Others

Recommended Reports

Pain Management Drugs

Corticosteroid & Injection

Joint & Spine Therapies

1 Corticosteroid Injections for Joint Pain Market Overview
1.1 Product Definition
1.2 Corticosteroid Injections for Joint Pain by Type
1.2.1 Global Corticosteroid Injections for Joint Pain Market Value Comparison by Type (2024 VS 2031)
1.2.2 Knee & Ankle
1.2.3 Hip Joint
1.2.4 Shoulder & Elbow
1.2.5 Facet Joints of the Spine
1.2.6 Others
1.3 Corticosteroid Injections for Joint Pain by Application
1.3.1 Global Corticosteroid Injections for Joint Pain Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Corticosteroid Injections for Joint Pain Market Size Estimates and Forecasts
1.4.1 Global Corticosteroid Injections for Joint Pain Revenue 2020-2031
1.4.2 Global Corticosteroid Injections for Joint Pain Sales 2020-2031
1.4.3 Global Corticosteroid Injections for Joint Pain Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Corticosteroid Injections for Joint Pain Market Competition by Manufacturers
2.1 Global Corticosteroid Injections for Joint Pain Sales Market Share by Manufacturers (2020-2025)
2.2 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Corticosteroid Injections for Joint Pain Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Corticosteroid Injections for Joint Pain, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Corticosteroid Injections for Joint Pain, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Corticosteroid Injections for Joint Pain, Product Type & Application
2.7 Global Key Manufacturers of Corticosteroid Injections for Joint Pain, Date of Enter into This Industry
2.8 Global Corticosteroid Injections for Joint Pain Market Competitive Situation and Trends
2.8.1 Global Corticosteroid Injections for Joint Pain Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Corticosteroid Injections for Joint Pain Players Market Share by Revenue
2.8.3 Global Corticosteroid Injections for Joint Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Corticosteroid Injections for Joint Pain Market Scenario by Region
3.1 Global Corticosteroid Injections for Joint Pain Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Corticosteroid Injections for Joint Pain Sales by Region: 2020-2031
3.2.1 Global Corticosteroid Injections for Joint Pain Sales by Region: 2020-2025
3.2.2 Global Corticosteroid Injections for Joint Pain Sales by Region: 2026-2031
3.3 Global Corticosteroid Injections for Joint Pain Revenue by Region: 2020-2031
3.3.1 Global Corticosteroid Injections for Joint Pain Revenue by Region: 2020-2025
3.3.2 Global Corticosteroid Injections for Joint Pain Revenue by Region: 2026-2031
3.4 North America Corticosteroid Injections for Joint Pain Market Facts & Figures by Country
3.4.1 North America Corticosteroid Injections for Joint Pain Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Corticosteroid Injections for Joint Pain Sales by Country (2020-2031)
3.4.3 North America Corticosteroid Injections for Joint Pain Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Corticosteroid Injections for Joint Pain Market Facts & Figures by Country
3.5.1 Europe Corticosteroid Injections for Joint Pain Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Corticosteroid Injections for Joint Pain Sales by Country (2020-2031)
3.5.3 Europe Corticosteroid Injections for Joint Pain Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Corticosteroid Injections for Joint Pain Market Facts & Figures by Region
3.6.1 Asia Pacific Corticosteroid Injections for Joint Pain Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Corticosteroid Injections for Joint Pain Sales by Region (2020-2031)
3.6.3 Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Corticosteroid Injections for Joint Pain Market Facts & Figures by Country
3.7.1 Latin America Corticosteroid Injections for Joint Pain Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Corticosteroid Injections for Joint Pain Sales by Country (2020-2031)
3.7.3 Latin America Corticosteroid Injections for Joint Pain Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Corticosteroid Injections for Joint Pain Market Facts & Figures by Country
3.8.1 Middle East and Africa Corticosteroid Injections for Joint Pain Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Country (2020-2031)
3.8.3 Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Corticosteroid Injections for Joint Pain Sales by Type (2020-2031)
4.1.1 Global Corticosteroid Injections for Joint Pain Sales by Type (2020-2025)
4.1.2 Global Corticosteroid Injections for Joint Pain Sales by Type (2026-2031)
4.1.3 Global Corticosteroid Injections for Joint Pain Sales Market Share by Type (2020-2031)
4.2 Global Corticosteroid Injections for Joint Pain Revenue by Type (2020-2031)
4.2.1 Global Corticosteroid Injections for Joint Pain Revenue by Type (2020-2025)
4.2.2 Global Corticosteroid Injections for Joint Pain Revenue by Type (2026-2031)
4.2.3 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2020-2031)
4.3 Global Corticosteroid Injections for Joint Pain Price by Type (2020-2031)
5 Segment by Application
5.1 Global Corticosteroid Injections for Joint Pain Sales by Application (2020-2031)
5.1.1 Global Corticosteroid Injections for Joint Pain Sales by Application (2020-2025)
5.1.2 Global Corticosteroid Injections for Joint Pain Sales by Application (2026-2031)
5.1.3 Global Corticosteroid Injections for Joint Pain Sales Market Share by Application (2020-2031)
5.2 Global Corticosteroid Injections for Joint Pain Revenue by Application (2020-2031)
5.2.1 Global Corticosteroid Injections for Joint Pain Revenue by Application (2020-2025)
5.2.2 Global Corticosteroid Injections for Joint Pain Revenue by Application (2026-2031)
5.2.3 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2020-2031)
5.3 Global Corticosteroid Injections for Joint Pain Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Company Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Allergan Corticosteroid Injections for Joint Pain Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Corticosteroid Injections for Joint Pain Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Corticosteroid Injections for Joint Pain Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Anika Therapeutics
6.4.1 Anika Therapeutics Company Information
6.4.2 Anika Therapeutics Description and Business Overview
6.4.3 Anika Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Anika Therapeutics Corticosteroid Injections for Joint Pain Product Portfolio
6.4.5 Anika Therapeutics Recent Developments/Updates
6.5 Ferring
6.5.1 Ferring Company Information
6.5.2 Ferring Description and Business Overview
6.5.3 Ferring Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Ferring Corticosteroid Injections for Joint Pain Product Portfolio
6.5.5 Ferring Recent Developments/Updates
6.6 Bioventus
6.6.1 Bioventus Company Information
6.6.2 Bioventus Description and Business Overview
6.6.3 Bioventus Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bioventus Corticosteroid Injections for Joint Pain Product Portfolio
6.6.5 Bioventus Recent Developments/Updates
6.7 Flexion Therapeutics
6.7.1 Flexion Therapeutics Company Information
6.7.2 Flexion Therapeutics Description and Business Overview
6.7.3 Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Flexion Therapeutics Corticosteroid Injections for Joint Pain Product Portfolio
6.7.5 Flexion Therapeutics Recent Developments/Updates
6.8 Zimmer Biomet
6.8.1 Zimmer Biomet Company Information
6.8.2 Zimmer Biomet Description and Business Overview
6.8.3 Zimmer Biomet Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Zimmer Biomet Corticosteroid Injections for Joint Pain Product Portfolio
6.8.5 Zimmer Biomet Recent Developments/Updates
6.9 SEIKAGAKU
6.9.1 SEIKAGAKU Company Information
6.9.2 SEIKAGAKU Description and Business Overview
6.9.3 SEIKAGAKU Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2020-2025)
6.9.4 SEIKAGAKU Corticosteroid Injections for Joint Pain Product Portfolio
6.9.5 SEIKAGAKU Recent Developments/Updates
6.10 Chugai Pharma
6.10.1 Chugai Pharma Company Information
6.10.2 Chugai Pharma Description and Business Overview
6.10.3 Chugai Pharma Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Chugai Pharma Corticosteroid Injections for Joint Pain Product Portfolio
6.10.5 Chugai Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Corticosteroid Injections for Joint Pain Industry Chain Analysis
7.2 Corticosteroid Injections for Joint Pain Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Corticosteroid Injections for Joint Pain Production Mode & Process Analysis
7.4 Corticosteroid Injections for Joint Pain Sales and Marketing
7.4.1 Corticosteroid Injections for Joint Pain Sales Channels
7.4.2 Corticosteroid Injections for Joint Pain Distributors
7.5 Corticosteroid Injections for Joint Pain Customer Analysis
8 Corticosteroid Injections for Joint Pain Market Dynamics
8.1 Corticosteroid Injections for Joint Pain Industry Trends
8.2 Corticosteroid Injections for Joint Pain Market Drivers
8.3 Corticosteroid Injections for Joint Pain Market Challenges
8.4 Corticosteroid Injections for Joint Pain Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Corticosteroid Injections for Joint Pain Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Corticosteroid Injections for Joint Pain Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Corticosteroid Injections for Joint Pain Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Corticosteroid Injections for Joint Pain Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global Corticosteroid Injections for Joint Pain Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Corticosteroid Injections for Joint Pain Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Corticosteroid Injections for Joint Pain Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Corticosteroid Injections for Joint Pain Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Corticosteroid Injections for Joint Pain, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Corticosteroid Injections for Joint Pain, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Corticosteroid Injections for Joint Pain, Product Type & Application
 Table 12. Global Key Manufacturers of Corticosteroid Injections for Joint Pain, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Corticosteroid Injections for Joint Pain by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Corticosteroid Injections for Joint Pain as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Corticosteroid Injections for Joint Pain Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Corticosteroid Injections for Joint Pain Sales by Region (2020-2025) & (Units)
 Table 18. Global Corticosteroid Injections for Joint Pain Sales Market Share by Region (2020-2025)
 Table 19. Global Corticosteroid Injections for Joint Pain Sales by Region (2026-2031) & (Units)
 Table 20. Global Corticosteroid Injections for Joint Pain Sales Market Share by Region (2026-2031)
 Table 21. Global Corticosteroid Injections for Joint Pain Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Region (2020-2025)
 Table 23. Global Corticosteroid Injections for Joint Pain Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Region (2026-2031)
 Table 25. North America Corticosteroid Injections for Joint Pain Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Corticosteroid Injections for Joint Pain Sales by Country (2020-2025) & (Units)
 Table 27. North America Corticosteroid Injections for Joint Pain Sales by Country (2026-2031) & (Units)
 Table 28. North America Corticosteroid Injections for Joint Pain Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Corticosteroid Injections for Joint Pain Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Corticosteroid Injections for Joint Pain Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Corticosteroid Injections for Joint Pain Sales by Country (2020-2025) & (Units)
 Table 32. Europe Corticosteroid Injections for Joint Pain Sales by Country (2026-2031) & (Units)
 Table 33. Europe Corticosteroid Injections for Joint Pain Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Corticosteroid Injections for Joint Pain Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Corticosteroid Injections for Joint Pain Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific Corticosteroid Injections for Joint Pain Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Corticosteroid Injections for Joint Pain Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Corticosteroid Injections for Joint Pain Sales by Country (2020-2025) & (Units)
 Table 42. Latin America Corticosteroid Injections for Joint Pain Sales by Country (2026-2031) & (Units)
 Table 43. Latin America Corticosteroid Injections for Joint Pain Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Corticosteroid Injections for Joint Pain Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Corticosteroid Injections for Joint Pain Sales (Units) by Type (2020-2025)
 Table 51. Global Corticosteroid Injections for Joint Pain Sales (Units) by Type (2026-2031)
 Table 52. Global Corticosteroid Injections for Joint Pain Sales Market Share by Type (2020-2025)
 Table 53. Global Corticosteroid Injections for Joint Pain Sales Market Share by Type (2026-2031)
 Table 54. Global Corticosteroid Injections for Joint Pain Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Corticosteroid Injections for Joint Pain Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2020-2025)
 Table 57. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2026-2031)
 Table 58. Global Corticosteroid Injections for Joint Pain Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Corticosteroid Injections for Joint Pain Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Corticosteroid Injections for Joint Pain Sales (Units) by Application (2020-2025)
 Table 61. Global Corticosteroid Injections for Joint Pain Sales (Units) by Application (2026-2031)
 Table 62. Global Corticosteroid Injections for Joint Pain Sales Market Share by Application (2020-2025)
 Table 63. Global Corticosteroid Injections for Joint Pain Sales Market Share by Application (2026-2031)
 Table 64. Global Corticosteroid Injections for Joint Pain Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Corticosteroid Injections for Joint Pain Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2020-2025)
 Table 67. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2026-2031)
 Table 68. Global Corticosteroid Injections for Joint Pain Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Corticosteroid Injections for Joint Pain Price (USD/Unit) by Application (2026-2031)
 Table 70. Allergan Company Information
 Table 71. Allergan Description and Business Overview
 Table 72. Allergan Corticosteroid Injections for Joint Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Allergan Corticosteroid Injections for Joint Pain Product
 Table 74. Allergan Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Corticosteroid Injections for Joint Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer Corticosteroid Injections for Joint Pain Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Corticosteroid Injections for Joint Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Sanofi Corticosteroid Injections for Joint Pain Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. Anika Therapeutics Company Information
 Table 86. Anika Therapeutics Description and Business Overview
 Table 87. Anika Therapeutics Corticosteroid Injections for Joint Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Anika Therapeutics Corticosteroid Injections for Joint Pain Product
 Table 89. Anika Therapeutics Recent Developments/Updates
 Table 90. Ferring Company Information
 Table 91. Ferring Description and Business Overview
 Table 92. Ferring Corticosteroid Injections for Joint Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Ferring Corticosteroid Injections for Joint Pain Product
 Table 94. Ferring Recent Developments/Updates
 Table 95. Bioventus Company Information
 Table 96. Bioventus Description and Business Overview
 Table 97. Bioventus Corticosteroid Injections for Joint Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Bioventus Corticosteroid Injections for Joint Pain Product
 Table 99. Bioventus Recent Developments/Updates
 Table 100. Flexion Therapeutics Company Information
 Table 101. Flexion Therapeutics Description and Business Overview
 Table 102. Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Flexion Therapeutics Corticosteroid Injections for Joint Pain Product
 Table 104. Flexion Therapeutics Recent Developments/Updates
 Table 105. Zimmer Biomet Company Information
 Table 106. Zimmer Biomet Description and Business Overview
 Table 107. Zimmer Biomet Corticosteroid Injections for Joint Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Zimmer Biomet Corticosteroid Injections for Joint Pain Product
 Table 109. Zimmer Biomet Recent Developments/Updates
 Table 110. SEIKAGAKU Company Information
 Table 111. SEIKAGAKU Description and Business Overview
 Table 112. SEIKAGAKU Corticosteroid Injections for Joint Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. SEIKAGAKU Corticosteroid Injections for Joint Pain Product
 Table 114. SEIKAGAKU Recent Developments/Updates
 Table 115. Chugai Pharma Company Information
 Table 116. Chugai Pharma Description and Business Overview
 Table 117. Chugai Pharma Corticosteroid Injections for Joint Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Chugai Pharma Corticosteroid Injections for Joint Pain Product
 Table 119. Chugai Pharma Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Corticosteroid Injections for Joint Pain Distributors List
 Table 123. Corticosteroid Injections for Joint Pain Customers List
 Table 124. Corticosteroid Injections for Joint Pain Market Trends
 Table 125. Corticosteroid Injections for Joint Pain Market Drivers
 Table 126. Corticosteroid Injections for Joint Pain Market Challenges
 Table 127. Corticosteroid Injections for Joint Pain Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Corticosteroid Injections for Joint Pain
 Figure 2. Global Corticosteroid Injections for Joint Pain Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Corticosteroid Injections for Joint Pain Market Share by Type: 2024 & 2031
 Figure 4. Knee & Ankle Product Picture
 Figure 5. Hip Joint Product Picture
 Figure 6. Shoulder & Elbow Product Picture
 Figure 7. Facet Joints of the Spine Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Corticosteroid Injections for Joint Pain Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Corticosteroid Injections for Joint Pain Market Share by Application: 2024 & 2031
 Figure 11. Hospital Pharmacies
 Figure 12. Retail Pharmacies
 Figure 13. Online Pharmacies
 Figure 14. Global Corticosteroid Injections for Joint Pain Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Corticosteroid Injections for Joint Pain Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Corticosteroid Injections for Joint Pain Sales (2020-2031) & (Units)
 Figure 17. Global Corticosteroid Injections for Joint Pain Average Price (USD/Unit) & (2020-2031)
 Figure 18. Corticosteroid Injections for Joint Pain Report Years Considered
 Figure 19. Corticosteroid Injections for Joint Pain Sales Share by Manufacturers in 2024
 Figure 20. Global Corticosteroid Injections for Joint Pain Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Corticosteroid Injections for Joint Pain Players: Market Share by Revenue in Corticosteroid Injections for Joint Pain in 2024
 Figure 22. Corticosteroid Injections for Joint Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Corticosteroid Injections for Joint Pain Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Corticosteroid Injections for Joint Pain Sales Market Share by Country (2020-2031)
 Figure 25. North America Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Corticosteroid Injections for Joint Pain Sales Market Share by Country (2020-2031)
 Figure 29. Europe Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Corticosteroid Injections for Joint Pain Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Corticosteroid Injections for Joint Pain Revenue Market Share by Region (2020-2031)
 Figure 37. China Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Corticosteroid Injections for Joint Pain Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Corticosteroid Injections for Joint Pain Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Corticosteroid Injections for Joint Pain Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Corticosteroid Injections for Joint Pain by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Corticosteroid Injections for Joint Pain by Type (2020-2031)
 Figure 59. Global Corticosteroid Injections for Joint Pain Price (USD/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Corticosteroid Injections for Joint Pain by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Corticosteroid Injections for Joint Pain by Application (2020-2031)
 Figure 62. Global Corticosteroid Injections for Joint Pain Price (USD/Unit) by Application (2020-2031)
 Figure 63. Corticosteroid Injections for Joint Pain Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India